Asymchem

Asymchem Laboratories, Inc. owns Asymchem Laboratories (Tianjin) Inc., a Chinese company established in 1998 that specializes in the research and development of pharmaceutical raw materials synthesis technology. This technology is integral to drug development and production, serving both large and medium-sized pharmaceutical companies in Europe and America. Asymchem Laboratories (Tianjin) Inc. boasts over 400 independent synthetic techniques and nearly 3,500 products, showcasing its extensive capabilities in the field. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering solutions throughout the drug development and manufacturing process, including clinical and commercial stages. Its team consists of experienced professionals who have worked in significant pharmaceutical companies and American universities, contributing to its innovative approach and commercial application of pharmaceutical technology in both the Chinese mainland and international markets.

Hao Hong

Chairman and CEO

Rui Yang

COO

1 past transactions

LaNova Medicines

Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.